The Conversation (0)
OxySure Systems, Inc. (OTCQB:OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology announced that its OxySure Model 615 portable emergency oxygen device received CE Mark approval. This is an important step toward introducing the device to the European Economic Area. With the OxySure Model 615, any adult may quickly and easily administer medical oxygen if needed before paramedics or first responders are able to arrive at the scene of an emergency.
OxySure Systems, Inc. (OTCQB:OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology announced that its OxySure Model 615 portable emergency oxygen device received CE Mark approval. This is an important step toward introducing the device to the European Economic Area. With the OxySure Model 615, any adult may quickly and easily administer medical oxygen if needed before paramedics or first responders are able to arrive at the scene of an emergency.
As quoted in the press release:
Model 615 has already been used in connection with thousands of saves in the US alone including cardiac arrest, asthma attacks, sickle cell disease issues, COPD exacerbations, allergy attacks, heat exhaustion, hypoxia/altitude sickness, migraine attacks, poisoning and diabetic emergencies. Like the US, European first responders typically provide supplemental oxygen to patients immediately upon arrival. OxySure’s Model 615 allows lay rescuers to begin oxygen delivery sooner, bridging the gap until professional responders arrive on the scene.
OxySure CEO, Julian T. Ross, said:
Our product can now bear the CE Mark, which demonstrates that the OxySure Model 615 complies with stringent requirements related to the quality, safety, and performance of medical oxygen devices found in the applicable EU laws.
Click here to read the OxySure Systems, Inc. (OTCQB:OXYS) press release
